FI970095L - Uudet kemialliset yhdisteet, niiden valmistus ja niiden käyttö lääkeaineena - Google Patents

Uudet kemialliset yhdisteet, niiden valmistus ja niiden käyttö lääkeaineena Download PDF

Info

Publication number: FI970095L
Authority: FI; Finland
Prior art keywords: pharmaceuticals; preparation; chemical compounds; new chemical; new
Prior art date: 1994-07-13

Application number

FI970095A

Other languages

English (en)

Swedish (sv)

Other versions

FI970095A7 (fi

FI970095A0 (fi

Inventor

Ralf Anderskewitz

Kurt Schromm

Ernst-Otto Renth

Franz Birke

Armin Fuegner

Hubert Heuer

Christopher Meade

Original Assignee

Boehringer Ingelheim Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-13

Filing date

1995-06-03

Publication date

1997-01-10

1995-06-03 Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg

1997-01-10 Publication of FI970095A7 publication Critical patent/FI970095A7/fi

1997-01-10 Publication of FI970095L publication Critical patent/FI970095L/fi

1997-01-10 Publication of FI970095A0 publication Critical patent/FI970095A0/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

FI970095A 1994-07-13 1995-06-03 Uudet kemialliset yhdisteet, niiden valmistus ja niiden käyttö lääkeaineena FI970095A0 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4424714A DE4424714A1 (de)	1994-07-13	1994-07-13	Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff
PCT/EP1995/002113 WO1996002496A1 (de)	1994-07-13	1995-06-03	Neue chemische verbindung, ihre herstellung und ihre verwendung als arzneistoff

Publications (3)

Publication Number	Publication Date
FI970095A7 FI970095A7 (fi)	1997-01-10
FI970095L true FI970095L (fi)	1997-01-10
FI970095A0 FI970095A0 (fi)	1997-01-10

Family

ID=6523048

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI970095A FI970095A0 (fi)	1994-07-13	1995-06-03	Uudet kemialliset yhdisteet, niiden valmistus ja niiden käyttö lääkeaineena

Country Status (25)

Country	Link
US (1)	US5686496A (fi)
EP (1)	EP0770058A1 (fi)
JP (1)	JPH10502646A (fi)
KR (1)	KR970704674A (fi)
CN (1)	CN1152303A (fi)
AU (1)	AU2736895A (fi)
BG (1)	BG101104A (fi)
BR (1)	BR9508395A (fi)
CA (1)	CA2194886A1 (fi)
CO (1)	CO4410185A1 (fi)
CZ (1)	CZ8297A3 (fi)
DE (1)	DE4424714A1 (fi)
EE (1)	EE9700065A (fi)
FI (1)	FI970095A0 (fi)
HR (1)	HRP950363A2 (fi)
HU (1)	HUT76827A (fi)
IL (1)	IL114572A0 (fi)
MX (1)	MX9700245A (fi)
NO (1)	NO970123D0 (fi)
PE (1)	PE35196A1 (fi)
PL (1)	PL318114A1 (fi)
SK (1)	SK1897A3 (fi)
WO (1)	WO1996002496A1 (fi)
YU (1)	YU45395A (fi)
ZA (1)	ZA955781B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6191169B1 (en)	1992-08-28	2001-02-20	City Of Hope	Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
US6486181B1 (en)	1992-08-28	2002-11-26	City Of Hope	Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
EP0743064A1 (en) *	1995-05-17	1996-11-20	Eli Lilly And Company	Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease
DE19546452A1 (de) *	1995-12-13	1997-06-19	Boehringer Ingelheim Kg	Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
DE19636689A1 (de) *	1996-09-10	1998-03-12	Boehringer Ingelheim Kg	Neue Benzamidinderivate
DE19718334A1 (de) *	1997-04-30	1998-11-05	Boehringer Ingelheim Pharma	Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ID24720A (id)	1997-12-12	2000-08-03	Novartis Ag	Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
DE19834713A1 (de) *	1998-07-31	2000-02-03	Boehringer Ingelheim Pharma	Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6528491B2 (en) *	2000-10-24	2003-03-04	Boehringer Ingelheim Pharma Kg	Pyranoside derivatives
MXPA03006328A (es) *	2001-01-16	2004-04-05	Boehringer Ingelheim Pharma	Uso de antagonista de ltb4 para tratamiento y/o prevencion de enfermedades causadas por aumento de expresion de genes de mucina.
US20040006092A1 (en) *	2001-08-31	2004-01-08	Neurochem, Inc.	Amidine derivatives for treating amyloidosis
EP1623231A2 (en) *	2003-05-06	2006-02-08	Bayer HealthCare AG	Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)
US7262223B2 (en) *	2004-01-23	2007-08-28	Neurochem (International) Limited	Amidine derivatives for treating amyloidosis
KR100682199B1 (ko) *	2004-07-05	2007-02-12	동화약품공업주식회사	알러지성 염증 질환의 예방 및 치료용 조성물
DE602005023797D1 (de) *	2004-07-14	2010-11-04	Inflammation Res Ct Co Ltd	Verfahren zur Hemmung von Tumormetastasierung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0518818A3 (en) *	1991-06-11	1993-04-28	Ciba-Geigy Ag	Arylethers, their manufacture and use as medicament
PL173781B1 (pl) *	1992-02-05	1998-04-30	Boehringer Ingelheim Kg	Sposób wytwarzania nowych pochodnych amidyny

1994
- 1994-07-13 DE DE4424714A patent/DE4424714A1/de not_active Withdrawn
1995
- 1995-06-03 BR BR9508395A patent/BR9508395A/pt unknown
- 1995-06-03 CZ CZ9782A patent/CZ8297A3/cs unknown
- 1995-06-03 CN CN95194047A patent/CN1152303A/zh active Pending
- 1995-06-03 MX MX9700245A patent/MX9700245A/es unknown
- 1995-06-03 AU AU27368/95A patent/AU2736895A/en not_active Abandoned
- 1995-06-03 SK SK18-97A patent/SK1897A3/sk unknown
- 1995-06-03 KR KR1019970700123A patent/KR970704674A/ko not_active Withdrawn
- 1995-06-03 US US08/765,527 patent/US5686496A/en not_active Expired - Fee Related
- 1995-06-03 EE EE9700065A patent/EE9700065A/xx unknown
- 1995-06-03 CA CA002194886A patent/CA2194886A1/en not_active Abandoned
- 1995-06-03 FI FI970095A patent/FI970095A0/fi not_active Application Discontinuation
- 1995-06-03 EP EP95922492A patent/EP0770058A1/de not_active Withdrawn
- 1995-06-03 HU HU9700060A patent/HUT76827A/hu unknown
- 1995-06-03 JP JP8504619A patent/JPH10502646A/ja active Pending
- 1995-06-03 PL PL95318114A patent/PL318114A1/xx unknown
- 1995-06-03 WO PCT/EP1995/002113 patent/WO1996002496A1/de not_active Ceased
- 1995-06-27 HR HRP4424714.1A patent/HRP950363A2/xx not_active Application Discontinuation
- 1995-07-06 YU YU45395A patent/YU45395A/sh unknown
- 1995-07-11 PE PE1995273520A patent/PE35196A1/es not_active Application Discontinuation
- 1995-07-12 IL IL11457295A patent/IL114572A0/xx unknown
- 1995-07-12 ZA ZA955781A patent/ZA955781B/xx unknown
- 1995-07-12 CO CO95030620A patent/CO4410185A1/es unknown
1997
- 1997-01-04 BG BG101104A patent/BG101104A/xx unknown
- 1997-01-10 NO NO970123A patent/NO970123D0/no unknown

Also Published As

Publication number	Publication date
FI970095A7 (fi)	1997-01-10
CZ8297A3 (en)	1997-09-17
JPH10502646A (ja)	1998-03-10
HUT76827A (en)	1997-11-28
CO4410185A1 (es)	1997-01-09
ZA955781B (en)	1996-02-22
PE35196A1 (es)	1996-09-05
YU45395A (sh)	1997-12-05
IL114572A0 (en)	1995-11-27
EE9700065A (et)	1997-08-15
EP0770058A1 (de)	1997-05-02
CN1152303A (zh)	1997-06-18
CA2194886A1 (en)	1996-02-01
NO970123L (no)	1997-01-10
BG101104A (en)	1998-04-30
PL318114A1 (en)	1997-05-12
HU9700060D0 (en)	1997-02-28
DE4424714A1 (de)	1996-01-18
HRP950363A2 (en)	1997-08-31
SK1897A3 (en)	1997-08-06
US5686496A (en)	1997-11-11
BR9508395A (pt)	1997-12-23
FI970095A0 (fi)	1997-01-10
MX9700245A (es)	1997-05-31
NO970123D0 (no)	1997-01-10
KR970704674A (ko)	1997-09-06
AU2736895A (en)	1996-02-16
WO1996002496A1 (de)	1996-02-01

Publication	Publication Date	Title
FI961219A7 (fi)	1996-05-15	Kemialliset yhdisteet, niiden valmistus ja käyttö
FI941378L (fi)	1994-09-25	Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
FI955913A7 (fi)	1995-12-08	Uudet erytromysiinijohdannaiset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI964395L (fi)	1996-10-31	Uudet erytromysiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI945281L (fi)	1995-05-11	Heterosykliset yhdisteet, niiden valmistus ja käyttö
EE9900147A (et)	1999-12-15	Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
FI943687L (fi)	1995-03-21	Uudet 11-bentsaldoksiimiestradieenijohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet
FI950709L (fi)	1995-09-18	Organometalliset fluorenyyliyhdisteet, valmistus ja käyttö
EE9900359A (et)	2000-02-15	Diasendatud bitsüklilised heterotsüklid, nende valmistamine ja kasutamine ravimitena
EE200000468A (et)	2002-04-15	Ühendid, nende kasutamine ja farmatseutiline kompositsioon
FI931901A7 (fi)	1993-10-29	Atsoliyhdisteet, niiden valmistus ja käyttö
EE9700044A (et)	1997-08-15	Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid.
FI955235A7 (fi)	1996-05-03	Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
EE9700020A (et)	1997-08-15	Heteroaatomit sisaldavad tsülopentaanpüridüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
FI970094A7 (fi)	1997-01-10	Substituoidut bentsamidiinit, niiden valmistus ja käyttö lääkeaineena
EE200000621A (et)	2002-06-17	Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine
EE200000037A (et)	2000-10-16	Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena
FI944417A7 (fi)	1995-03-25	Atsoliyhdisteet, niiden valmistus ja käyttö
FI970095L (fi)	1997-01-10	Uudet kemialliset yhdisteet, niiden valmistus ja niiden käyttö lääkeaineena
FI970997L (fi)	1997-03-10	Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö
EE200000129A (et)	2001-02-15	Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
FI953956A7 (fi)	1996-02-26	2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI954229L (fi)	1995-09-08	Heterosykliset yhdisteet, niiden käyttö ja valmistus
FI930716A7 (fi)	1993-08-21	Uusia aryylikarbonyyliaminoalkyylidihydro-oksopyridiinejä, niiden valmistus ja käyttö
TR199501553A2 (tr)	1996-07-21	Sefem bilesimleri ve bunlarin farmasötik olarak kullanilmasi.

Legal Events

Date	Code	Title	Description
1998-12-31	FD	Application lapsed